Bernard Vrijens is a prominent figure in the field of biostatistics and drug exposure research, currently serving as the Chief Executive Officer at Advanced Analytical Research on Drug Exposure (AARDEX Group). In addition to his leadership role, Dr. Vrijens is an Invited Professor of Biostatistics...
Bernard Vrijens is a prominent figure in the field of biostatistics and drug exposure research, currently serving as the Chief Executive Officer at Advanced Analytical Research on Drug Exposure (AARDEX Group). In addition to his leadership role, Dr. Vrijens is an Invited Professor of Biostatistics at the University of Liège, Belgium, where he imparts his extensive knowledge to students pursuing a Master in Public Health. His academic background, culminating in a PhD from the Department of Applied Mathematics and Informatics at Ghent University, equips him with a robust foundation in both theoretical and applied aspects of biostatistics.
At the University of Liège, Dr. Vrijens is deeply involved in teaching and mentoring students, focusing on the critical intersection of biostatistics and public health. His expertise spans various domains, including pharmacokinetics and pharmacodynamics, which are essential for understanding drug behavior in the body. He leads a research program that investigates medication adherence, a crucial factor in the effectiveness of therapeutic interventions, particularly in oncology and chronic disease management. Dr. Vrijens’s work emphasizes the importance of adherence in the pharmaceutical industry and life sciences, where understanding patient behavior can significantly influence treatment outcomes.
His skills in informatics and clinical research organizations (CROs) further enhance his contributions to the field, allowing him to integrate advanced analytical techniques into practical applications. Through his dual role in academia and industry, Dr. Vrijens bridges the gap between theoretical research and real-world applications, fostering a new generation of public health professionals equipped to tackle the complexities of medication adherence and drug exposure in diverse populations.